Literature DB >> 16371871

Age influences the emm type distribution of pediatric group A streptococcal pharyngeal isolates.

Preeti Jaggi1, Robert R Tanz, Bernard Beall, Stanford T Shulman.   

Abstract

BACKGROUND: emm types 12, 1, 28, 3, 4, 2 and 6 (in that order) are the types most commonly associated with uncomplicated group A streptococcal (GAS) pharyngitis in the United States, together accounting for approximately 78% of isolates.
OBJECTIVE: To determine whether the distribution of common pharyngeal group A streptococcal GAS types differs at various ages throughout childhood. STUDY
DESIGN: We emm typed 3356 GAS isolates collected from the United States and Canada during 3 streptococcal seasons (2000-2003). Variations in prevalence by age for the 7 most prevalent emm types and the "uncommon" category (all types accounting for <5% of the total number of isolates) were analyzed and assessed for significance by chi2.
RESULTS: The proportion of uncommon isolates increased significantly with increasing age from 18% in group 1 to 37% in group 4 (P = 0.001). We found a significant decrease in the proportion of the common pharyngeal emm types, specifically emm 12 and emm 4 type isolates, with increasing age (P = 0.001 and P = 0.003, respectively); there was no significant decline in the prevalence of other common pharyngeal types (emm 1, 2, 3, 6 and 28) with increasing age.
CONCLUSION: Age-related changes in emm type distribution of pharyngeal GAS are present in childhood; these changes may reflect acquisition of immunity to more common types as a consequence of exposure early in life, but this remains to be demonstrated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16371871     DOI: 10.1097/01.inf.0000190023.89759.96

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  8 in total

1.  Age-associated differences in prevalence of group A streptococcal type-specific M antibodies in children.

Authors:  Preeti Jaggi; James B Dale; Edna Chiang; Poonam Beniwal; William Kabat; Stanford T Shulman
Journal:  Eur J Pediatr       Date:  2008-09-24       Impact factor: 3.183

2.  Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles.

Authors:  Roger Meisal; Ida K G Andreasson; E Arne Høiby; Ingeborg S Aaberge; Terje E Michaelsen; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

3.  Naturally Acquired Protection Against Upper Respiratory Symptoms Involving Group A Streptococcus in a Longitudinal Cohort Study.

Authors:  Joseph A Lewnard; Lilith K Whittles; Anne-Marie Rick; Judith M Martin
Journal:  Clin Infect Dis       Date:  2020-11-05       Impact factor: 9.079

Review 4.  Population biology of the human restricted pathogen, Streptococcus pyogenes.

Authors:  Debra E Bessen
Journal:  Infect Genet Evol       Date:  2009-03-21       Impact factor: 3.342

5.  The dynamic nature of group A streptococcal epidemiology in tropical communities with high rates of rheumatic heart disease.

Authors:  M I McDonald; R J Towers; R Andrews; N Benger; P Fagan; B J Currie; J R Carapetis
Journal:  Epidemiol Infect       Date:  2007-05-31       Impact factor: 2.451

6.  Cryptic prophages within a Streptococcus pyogenes genotype emm4 lineage.

Authors:  Alex Remmington; Samuel Haywood; Julia Edgar; Luke R Green; Thushan de Silva; Claire E Turner
Journal:  Microb Genom       Date:  2020-11-27

7.  Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece.

Authors:  George A Syrogiannopoulos; Ioanna N Grivea; Adnan Al-Lahham; Maria Panagiotou; Alexandra G Tsantouli; Aspasia N Michoula Ralf René Reinert; Mark van der Linden
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

8.  Scarlet Fever Upsurge in England and Molecular-Genetic Analysis in North-West London, 2014.

Authors:  Claire E Turner; Marta Pyzio; Bonita Song; Theresa Lamagni; Margie Meltzer; J Yimmy Chow; Androulla Efstratiou; Sally Curtis; Shiranee Sriskandan
Journal:  Emerg Infect Dis       Date:  2016-06       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.